probenecid (colbenemid) Report issue

Small molecule Approved FDA
PubChem

Active Ingredient History

NOW
  • Now
Probenecid, also sold under the brand name Probalan, is a medication that increases uric acid excretion in the urine. It is primarily used in treating gout and hyperuricemia.   Wikipedia

Chemistry

More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: Missing data
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: Missing data

Drug Pricing (per unit)

Australia

$0.3966

United States

$0.5810 - $0.7897
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

Alternative names

colbenemid

Organizations (20)

Research & Development (19)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (1)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (14)

Approved Indications (1)


 

Gout (approved 1951)

Experimental Indications - Clinical Trial Phases 1-4 (13)


 

Alcoholism (Phase 1)

Bacterial Infections (Phase 1/Phase 2)

Chronic Pain (Phase 2/Phase 3)

Diabetes Mellitus (Phase 1)

Diabetes Mellitus, Type 2 (Phase 1)

Drug Interactions (Phase 1)

Fontan Procedure (Phase 4)

Healthy Volunteers (Phase 1)

Heart Failure (Phase 2/Phase 3)

Intraabdominal Infections (Phase 3)

Morphine Dependence (Phase 2/Phase 3)

Substance Withdrawal Syndrome (Phase 2/Phase 3)

Urinary Tract Infections (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 20
  • # of Trial Organizations: 19

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue